This inventor holds 1 USPTO granted patent. Top assignee: Amylin Pharmaceuticals, Inc.. Active years: 2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000
Title: Kathleen Ann Brown: Innovator in Gastrointestinal Therapeutics
Introduction
Kathleen Ann Brown is a notable inventor based in Wake Forest, NC (US). She has made significant contributions to the field of gastrointestinal therapeutics, particularly through her innovative patent.
Latest Patents
Kathleen holds a patent titled "Methods for regulating gastrointestinal motility." This patent discloses methods for treating conditions associated with elevated, inappropriate, or undesired post-prandial blood glucose levels. The methods involve the administration of an effective amount of an amylin agonist, either alone or in conjunction with other anti-gastric emptying agents. Additionally, her patent describes methods for reducing gastric motility and delaying gastric emptying for both therapeutic and diagnostic purposes. She has 1 patent to her name.
Career Highlights
Kathleen is associated with Amylin Pharmaceuticals, Inc., where she applies her expertise in developing innovative solutions for gastrointestinal health. Her work has the potential to improve the quality of life for individuals suffering from related conditions.
Collaborations
Some of her notable coworkers include Orville G Kolterman and Andrew A Young, who have collaborated with her on various projects within the company.
Conclusion
Kathleen Ann Brown's contributions to gastrointestinal therapeutics through her patent demonstrate her commitment to innovation in healthcare. Her work continues to pave the way for advancements in the treatment of gastrointestinal conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile